WearLinq Announces Acquisition of AMI Cardiac Monitoring, LLC

WearLinq, a leading provider of wearable health monitoring and diagnosis solutions, has announced the acquisition of AMI Cardiac Monitoring, LLC, an established independent diagnostic testing facility (IDTF) with more than 33 years of expertise in ambulatory cardiac monitoring. This strategic acquisition will fuel WearLinq’s capacity to offer expansive clinical services across all 50 states and provide more patients access to its eWave 6-lead wearable ECG monitor, which recently received FDA 510(k) clearance. This announcement comes on the heels of a successful close of $6.7 million in early-stage investment from SpringTide, Social Impact Capital, Amino Capital, Berkeley Catalyst Fund, Human Longevity and angels from iRhythm and AliveCor.

Read the full article: WearLinq Announces Acquisition of AMI Cardiac Monitoring, LLC //

Source: https://www.businesswire.com/news/home/20240521325743/en/WearLinq-Announces-Acquisition-of-AMI-Cardiac-Monitoring-LLC-and-Expands-Clinical-Services-Nationwide-with-FDA-510-k-Cleared-6-Lead-ECG-Device

Scroll to Top